纤溶酶原激活物抑制剂-1（SERPINE1）基因多态性与急性淋巴细胞白血病患儿的骨坏死风险 - Suppr

Suppr

超能文献

Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.

作者信息

Bond Jonathan, Adams Stuart, Richards Susan, Vora Ajay, Mitchell Christopher, Goulden Nicholas

出版信息

Blood. 2011 Sep 1;118(9):2632-3. doi: 10.1182/blood-2011-05-355206.

DOI:10.1182/blood-2011-05-355206

PMID:21885611

Abstract

摘要

相似文献

Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia.

Blood. 2011 Sep 1;118(9):2632-3. doi: 10.1182/blood-2011-05-355206.

A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Blood. 2008 May 1;111(9):4496-9. doi: 10.1182/blood-2007-11-123885. Epub 2008 Feb 19.

Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.

Mol Genet Genomic Med. 2021 Jul;9(7):e1700. doi: 10.1002/mgg3.1700. Epub 2021 May 27.

Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models.

PLoS One. 2019 May 6;14(5):e0216328. doi: 10.1371/journal.pone.0216328. eCollection 2019.

Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.

Clin Pediatr (Phila). 2002 Jan-Feb;41(1):63-4. doi: 10.1177/000992280204100114.

Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.

J Pediatr Hematol Oncol. 2014 Jan;36(1):22-9. doi: 10.1097/MPH.0000000000000039.

Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.

Eur J Cancer. 2014 Oct;50(15):2685-94. doi: 10.1016/j.ejca.2014.06.023. Epub 2014 Jul 30.

Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.

Pediatr Hematol Oncol. 2006 Dec;23(8):625-9. doi: 10.1080/08880010600909938.

Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.

Lancet Oncol. 2012 Sep;13(9):906-15. doi: 10.1016/S1470-2045(12)70274-7. Epub 2012 Aug 15.

Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.

J Clin Oncol. 2000 Sep 15;18(18):3262-72. doi: 10.1200/JCO.2000.18.18.3262.

引用本文的文献

Prevalence of Osteonecrosis in Survivors of Childhood Acute Lymphoblastic Leukaemia of Indian Ethnicity Treated with BFM Protocol.

Indian J Hematol Blood Transfus. 2025 Apr;41(2):320-326. doi: 10.1007/s12288-024-01861-4. Epub 2024 Sep 5.

Mesenchymal stem cell-derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative review.

Biomater Transl. 2022 Sep 28;3(3):175-187. doi: 10.12336/biomatertransl.2022.03.002. eCollection 2022.

Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study.

J Clin Med. 2022 Apr 28;11(9):2489. doi: 10.3390/jcm11092489.

Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia.

Mol Genet Genomic Med. 2021 Jul;9(7):e1700. doi: 10.1002/mgg3.1700. Epub 2021 May 27.

Bone marrow mesenchymal stem cell-derived exosomes promote plasminogen activator inhibitor 1 expression in vascular cells in the local microenvironment during rabbit osteonecrosis of the femoral head.

Stem Cell Res Ther. 2020 Nov 11;11(1):480. doi: 10.1186/s13287-020-01991-2.

Association between genetic polymorphisms and osteonecrosis in steroid treatment populations: a detailed stratified and dose-response meta-analysis.

Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20190024. Print 2019 May 31.

Lipid Transporter Activity-Related Genetic Polymorphisms Are Associated With Steroid-Induced Osteonecrosis of the Femoral Head: An Updated Meta-Analysis Based on the GRADE Guidelines.

Front Physiol. 2018 Dec 3;9:1684. doi: 10.3389/fphys.2018.01684. eCollection 2018.

Skeletal Morbidity in Children and Adolescents during and following Cancer Therapy.

Horm Res Paediatr. 2019;91(2):137-151. doi: 10.1159/000494809. Epub 2018 Nov 27.

Association between plasminogen activator inhibitor gene polymorphisms and osteonecrosis of the femoral head susceptibility: A case-control study.

Medicine (Baltimore). 2017 Oct;96(42):e7047. doi: 10.1097/MD.0000000000007047.

Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep. 2017 Jun;12(3):176-186. doi: 10.1007/s11899-017-0376-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验